Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine

Clinical trial NCT03278132 · COMPLETED

Trial details

NCT number: NCT03278132
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hand, Foot and Mouth Disease

Start date: 2017-07-16
Primary completion: 2017-09-15
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.